Researchers discover test to predict which patients with rare blood disease will respond to only FDA-approved treatment, and identify alternative therapy
David Fajgenbaum and Sheila Pierson of the Perelman School of Medicine discuss their latest research and findings in the treatment of Castleman disease.
・ From Science Daily